title

Neurology® Neuroimmunology & Neuroinflammation Podcast

American Academy of Neurology

1
Followers
0
Plays
Neurology® Neuroimmunology & Neuroinflammation Podcast

Neurology® Neuroimmunology & Neuroinflammation Podcast

American Academy of Neurology

1
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Alert: There is an updated RSS feed for Neurology® Neuroimmunology & Neuroinflammation: http://www.aan.com/rss/index.cfm?event=feed.items&channel=1. The Neurology journals have combined all feeds into a central location to better serve subscribers. Neurology® Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology, provides neurologists and translationally minded scientists with peer-reviewed articles, editorials, and reviews to enhance patient care, education, and clinical & translational research.

Latest Episodes

August 2015 Issue

Josep O. Dalmau, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast inverview. Dr. Laura Benjamin interviews Dr. Don Gilden about his paper Widespread arterial infection by varicella zoster virus explains refractory giant cell arteritis. J. Damlau is the editor of Neurology: Neuroimmunology & Neuroinflammation, is on the editorial board for Neurology UpToDate, holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, IgLON5 autoantibody test, received research support from Euroimmun, NIH, Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government); L. Benjamin reports no disclosures; D. Gilden is a senior Associate editor for Journal of NeuroVirology, is on the editorial board for In Vivio, Journal of V

16 MIN2015 AUG 7
Comments
August 2015 Issue

June 2015 Issue

Josep O. Dalmau, Editor of Neurology: Neuroimmunology & Neuroinfammation discusses the introduces the podcast interview. Dr. Richard Lewis interviews Dr. Robert Miller about his paper A Randomized Phase 2 Trial of NP001-A Novel Immune Regulator: Safety and Early Efficacy in ALS J. Damlau is the editor of Neurology: Neuroimmunology & Neuroinflammation, is on the editorial board for Neurology UpToDate, holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, IgLON5 autoantibody test, received research support from Euroimmun, NIH, Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government). R.G. Miller is on the scientific advisory board for Cytokinetics, Mitsubishi Tanable, is on the editorial advisory board for Lancet Neurology, r

13 MIN2015 JUN 2
Comments
June 2015 Issue

April 2015 Issue

Josep O. Dalmau, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast inverview. Dr. Mark Freedman interviews Dr. Amit Bar-Or about his paper Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens. J. Damlau is the editor of Neurology: Neuroimmunology & Neuroinflammation, is on the editorial board for Neurology UpToDate, holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, IgLON5 autoantibody test, received research support from Euroimmun, NIH, Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government). M.S. Freedman is on the scientific advisory board for Actelion, Sanofi-Aventis/Genzyme, Novartis, Merck Serono, Bayer, BiogenIdec, Roche, Celgene, Opexa, Teva

14 MIN2015 APR 3
Comments
April 2015 Issue

February 2015 Issue

Josep O. Dalmau, Editor of Neurology: Neuroimmunology & Neuroinfammation discusses the transition to editorship and introduces the podcast inverview. Dr. Scott Zamvil interviews Dr. Illa Kister about her paper Disease exacerbation following Rituximab infusion in Neuromyelitis Optica J. Damlau is the editor of Neurology: Neuroimmunology & Neuroinflammation, is on the editorial board for Neurology UpToDate, holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, IgLON5 autoantibody test, received research support from Euroimmun, NIH, Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government). S.S. Zamvil received honoraria for serving on the data safety monitoring boards from BioMS, Teva Pharmaceuticals, Eli Lilly, is the deputy

16 MIN2015 FEB 5
Comments
February 2015 Issue

December 2014 Issue

Richard Ransohoff, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast initiative and the following interview. Dr. Josep Dalmau then interviews Dr. Neeta Garg about her paper on Leucine-rich glioma-inactivated protein1-antibody encephalitis: A case report Richard M. Ransohoff conducts research supported by the NIH, the National MS Society, the DOD, the Alzheimer's Association, the Guthy-Jackson Foundation, Williams Family Foundation for MS Research, ChemoCentryx, Lundbeck, Teva, Novartis, Genzyme, and Biogen-Idec. Dr. Ransohoff has received fees for preclinical consulting or honoraria for academic presentations from Amgen, Genentech, Roche, Novartis, Biogen-Idec, and Pfizer. He serves on scientific advisory, medical advisory, or safety monitoring boards for ChemoCentryx and Vertex. He receives an honorarium from the AAN as the Editor of Neurology: Neuroimmunolo

14 MIN2014 DEC 19
Comments
December 2014 Issue

October 2014 Issue

Ransohoff, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast initiative and the following interview. Dr. Scott Zamvil then interviews Dr. Oivind Torkildsen about his paper on treatment resistant immune thrombocytopenic purpura associated with low-dose naltrezone use in a patient with MS. Richard M. Ransohoff conducts research supported by the NIH, the National MS Society, the DOD, the Alzheimer's Association, the Guthy-Jackson Foundation, Williams Family Foundation for MS Research, ChemoCentryx, Lundbeck, Teva, Novartis, Genzyme, and Biogen-Idec. Dr. Ransohoff has received fees for preclinical consulting or honoraria for academic presentations from Amgen, Genentech, Roche, Novartis, Biogen-Idec, and Pfizer. He serves on scientific advisory, medical advisory, or safety monitoring boards for ChemoCentryx and Vertex. He receives an honorarium from the AAN as the

11 MIN2014 OCT 25
Comments
October 2014 Issue

August 2015 Issue

16 MIN2017 DEC 24
Comments
August 2015 Issue

June 2015 Issue

13 MIN2017 DEC 24
Comments
June 2015 Issue

April 2015 Issue

14 MIN2017 DEC 24
Comments
April 2015 Issue

February 2015 Issue

16 MIN2017 DEC 24
Comments
February 2015 Issue

Latest Episodes

August 2015 Issue

Josep O. Dalmau, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast inverview. Dr. Laura Benjamin interviews Dr. Don Gilden about his paper Widespread arterial infection by varicella zoster virus explains refractory giant cell arteritis. J. Damlau is the editor of Neurology: Neuroimmunology & Neuroinflammation, is on the editorial board for Neurology UpToDate, holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, IgLON5 autoantibody test, received research support from Euroimmun, NIH, Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government); L. Benjamin reports no disclosures; D. Gilden is a senior Associate editor for Journal of NeuroVirology, is on the editorial board for In Vivio, Journal of V

16 MIN2015 AUG 7
Comments
August 2015 Issue

June 2015 Issue

Josep O. Dalmau, Editor of Neurology: Neuroimmunology & Neuroinfammation discusses the introduces the podcast interview. Dr. Richard Lewis interviews Dr. Robert Miller about his paper A Randomized Phase 2 Trial of NP001-A Novel Immune Regulator: Safety and Early Efficacy in ALS J. Damlau is the editor of Neurology: Neuroimmunology & Neuroinflammation, is on the editorial board for Neurology UpToDate, holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, IgLON5 autoantibody test, received research support from Euroimmun, NIH, Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government). R.G. Miller is on the scientific advisory board for Cytokinetics, Mitsubishi Tanable, is on the editorial advisory board for Lancet Neurology, r

13 MIN2015 JUN 2
Comments
June 2015 Issue

April 2015 Issue

Josep O. Dalmau, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast inverview. Dr. Mark Freedman interviews Dr. Amit Bar-Or about his paper Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens. J. Damlau is the editor of Neurology: Neuroimmunology & Neuroinflammation, is on the editorial board for Neurology UpToDate, holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, IgLON5 autoantibody test, received research support from Euroimmun, NIH, Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government). M.S. Freedman is on the scientific advisory board for Actelion, Sanofi-Aventis/Genzyme, Novartis, Merck Serono, Bayer, BiogenIdec, Roche, Celgene, Opexa, Teva

14 MIN2015 APR 3
Comments
April 2015 Issue

February 2015 Issue

Josep O. Dalmau, Editor of Neurology: Neuroimmunology & Neuroinfammation discusses the transition to editorship and introduces the podcast inverview. Dr. Scott Zamvil interviews Dr. Illa Kister about her paper Disease exacerbation following Rituximab infusion in Neuromyelitis Optica J. Damlau is the editor of Neurology: Neuroimmunology & Neuroinflammation, is on the editorial board for Neurology UpToDate, holds patents for and receives royalties from Ma2 autoantibody test, NMDA receptor autoantibody test, GABA(B) receptor autoantibody test, GABA(A) receptor autoantibody test, DPPX autoantibody test, IgLON5 autoantibody test, received research support from Euroimmun, NIH, Fondo de Investigaciones Sanitarias de la Seguridad Social (Spanish Government). S.S. Zamvil received honoraria for serving on the data safety monitoring boards from BioMS, Teva Pharmaceuticals, Eli Lilly, is the deputy

16 MIN2015 FEB 5
Comments
February 2015 Issue

December 2014 Issue

Richard Ransohoff, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast initiative and the following interview. Dr. Josep Dalmau then interviews Dr. Neeta Garg about her paper on Leucine-rich glioma-inactivated protein1-antibody encephalitis: A case report Richard M. Ransohoff conducts research supported by the NIH, the National MS Society, the DOD, the Alzheimer's Association, the Guthy-Jackson Foundation, Williams Family Foundation for MS Research, ChemoCentryx, Lundbeck, Teva, Novartis, Genzyme, and Biogen-Idec. Dr. Ransohoff has received fees for preclinical consulting or honoraria for academic presentations from Amgen, Genentech, Roche, Novartis, Biogen-Idec, and Pfizer. He serves on scientific advisory, medical advisory, or safety monitoring boards for ChemoCentryx and Vertex. He receives an honorarium from the AAN as the Editor of Neurology: Neuroimmunolo

14 MIN2014 DEC 19
Comments
December 2014 Issue

October 2014 Issue

Ransohoff, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast initiative and the following interview. Dr. Scott Zamvil then interviews Dr. Oivind Torkildsen about his paper on treatment resistant immune thrombocytopenic purpura associated with low-dose naltrezone use in a patient with MS. Richard M. Ransohoff conducts research supported by the NIH, the National MS Society, the DOD, the Alzheimer's Association, the Guthy-Jackson Foundation, Williams Family Foundation for MS Research, ChemoCentryx, Lundbeck, Teva, Novartis, Genzyme, and Biogen-Idec. Dr. Ransohoff has received fees for preclinical consulting or honoraria for academic presentations from Amgen, Genentech, Roche, Novartis, Biogen-Idec, and Pfizer. He serves on scientific advisory, medical advisory, or safety monitoring boards for ChemoCentryx and Vertex. He receives an honorarium from the AAN as the

11 MIN2014 OCT 25
Comments
October 2014 Issue

August 2015 Issue

16 MIN2017 DEC 24
Comments
August 2015 Issue

June 2015 Issue

13 MIN2017 DEC 24
Comments
June 2015 Issue

April 2015 Issue

14 MIN2017 DEC 24
Comments
April 2015 Issue

February 2015 Issue

16 MIN2017 DEC 24
Comments
February 2015 Issue
hmly
himalayaプレミアムへようこそ聴き放題のオーディオブックをお楽しみください。